Beijing, China

Renyun Wang

USPTO Granted Patents = 2 


 

Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2015-2020

where 'Filed Patents' based on already Granted Patents

2 patents (USPTO):

Title: Renyun Wang: A Pioneer in Pharmaceutical Innovations

Introduction

Renyun Wang, based in Beijing, China, is an accomplished inventor with a focus on pharmaceutical innovations. With two patents to his name, Wang has made significant contributions to the field, particularly in diabetes management and drug formulation.

Latest Patents

Renyun Wang's recent patents include groundbreaking inventions that are transforming approaches to effective diabetes care. The first patent, titled "Insulin-lipid complex, preparation method therefor, and preparation thereof," introduces a novel insulin-lipid complex that enhances the delivery of insulin. This complex is created by combining insulin with lipid material in an organic solvent containing a low boiling point acid, followed by drying. The formulation's mass ratio of insulin to lipid material ranges from 1:3 to 1:20, providing versatility in its application.

The second patent focuses on the "Use of the effective fraction of alkaloids from mulberry twig in preparing hypoglycemic agents." This invention details a method for extracting an effective fraction of alkaloids from mulberry twig, which contains a high percentage of active compounds. Utilizing techniques such as solvent extraction and resin chromatography, Wang's patent offers a pharmaceutical composition that could significantly aid in the preparation of hypoglycemic agents.

Career Highlights

Renyun Wang's impressive career has seen him associated with prestigious research institutions, including the Chinese Academy of Medical Sciences and the Chinese Academy of Sciences. His research has not only contributed to innovative drug formulations but also to the overall understanding of diabetes management.

Collaborations

Throughout his career, Renyun Wang has collaborated with esteemed colleagues, including Yuling Liu and Xuejun Xia. These collaborations have fostered an environment of innovation and creativity, helping to bring forward important pharmaceutical advancements.

Conclusion

Renyun Wang's contributions to the field of pharmaceutical innovations underscore his commitment to improving healthcare outcomes, especially in diabetes treatment. With his inventive spirit and collaborative efforts, Wang continues to shape the future of medical science through his patented works, offering hope and solutions for patients worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…